DC
Decheng Capital
Venture CapitalActiveDecheng Capital is a global healthcare investment fund
38
Investments
7
Exits
$1.5B
AUM
18.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Decheng Capital.
Investment Thesis & Strategy
Decheng Capital invests in various stages of global healthcare companies, seeking innovative and impactful solutions across the healthcare spectrum.
Investment Activity
Deals per year over the last 7 years
5
20110
20120
20132
20141
20153
20161
2017Portfolio Companies
Selected investments from their portfolio of 38 companies
A
Adagene
Biotech · Growth, 2017
T
TransThera Biosciences
Biotech · Growth, 2016
A
Apollomics
Biotech · Growth, 2016
H
Harbour BioMed
Biotech · Growth, 2016
I
I-Mab
Biotech · Growth, 2015
Z
Zai Lab
Biotech · Growth, 2014
L
Legend Biotech
Biotech · Growth, 2014
W
Wuxi Biologics
Biotech · Growth, 2011
B
BeiGene
Biotech · Growth, 2011
C
CanSino Biologics
Biotech · Growth, 2011
E
Epizyme
Biotech · Growth, 2011
H
Hansoh Pharmaceutical
Biotech · Growth, 2011
Frequently Asked Questions
Decheng Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals
Khosla Ventures
Menlo Park, United States · 769 deals
Greylock
Menlo Park, United States · 720 deals
GGV Capital
Menlo Park, United States · 625 deals